Insmed INSM 深 沪
等待开盘 09-18 09:30:00 美东时间
144.78
+0.030
+0.02%
华盛通- 最 高146.50
- 今 开145.90
- 成交量 172.83万股
- 最 低 143.765
- 昨 收 144.75
- 总市值 305.49亿
- 52周最高 149.08
- 市盈率 静 --
- 换手率 0.82%
- 52周最低 60.40
- 委 比 -89.19%
- 总股本 2.11亿
- 历史最高 149.08
- 量 比 1.02
- 振 幅 1.89%
- 历史最低 2.64
- 每 手 1
- 风险率 22.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股盘后 | AppLovin Corporation涨6.95%，Robinhood涨6.56%
AppLovin Corporation涨6.95%；Robinhood涨6.56%；TransUnion涨3.35%
09-06 06:11
3 Stocks To Consider After Google's Favorable Anti-Trust Ruling
A federal judge's decision this week, allowing Google (NASDAQ:GOOG) to maintain...
09-06 00:54
Deep Dive Into Insmed Stock: Analyst Perspectives (26 Ratings)
Ratings for Insmed (NASDAQ:INSM) were provided by 26 analysts in the past three...
09-04 03:01
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $171
Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $140 to $171.
09-03 20:56
高盛将沃尔玛、瓦莱罗能源加入9月“确信名单”，还有这些公司入选
高盛在9月的确信名单中新增了四只股票，其中既包括美国一些最知名的品牌，也有部分能源股。 这些股票被纳入投资银行的“Conviction List - Dire...
09-03 13:45
Israel Englander's Millennium Goes All-In On Crypto And Healthcare While Rebalancing Big Tech Bets: Bitcoin ETF And Palantir Stakes Soar In Q2
Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalancing. Read key changes!
08-27 15:07
Hedge funds’ ‘rising and falling stars’ – stocks with the largest increases and decreases in popularity
Goldman Sachs analysts listed the stocks with the largest increases and decreases in hedge fund popularity during the second quarter. These are the companies hedge funds have shown the largest increas...
08-21 22:56
Insmed To Present at September Investor Conferences
BRIDGEWATER, N.J., Aug. 21, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...
08-21 19:00
Lung Disease-Focused Insmed 'Must-Own' Name For Investors
Insmed gains FDA approval for Brinsupri in bronchiectasis, while analysts see multi-billion sales potential from its expanding pipeline through 2035
08-21 02:46
Skechers, Tesla, and DoorDash among hedge funds’ new favorite long positions – GS
Goldman Sachs strategists highlighted their “VIP” list of stocks that “matter the most” to hedge funds, as they appear the most among their top 10 holdings. This list has outperformed the S&P 500 (SP5...
08-21 01:25
